MedMen Expands Product Portfolio with In-Demand Cannabis Brands, Exclusive Strains
December 6th, 2021
“More important than expansion itself is expanding with the right portfolio mix, one that excites consumers with new genetics and flavor profiles while delivering high-quality, consistent effects,” said Tyson Rossi, SVP of Product & Revenue, MedMen. “MedMen is always seeking the best cannabis brands – from small craft collectives to national celebrity brands – to better serve our diverse base of customers and patients.”
- Fireball: The official cannabis product of Fireball Whisky – 100mg packs of sativa-infused THC gummies, hand-crafted with signature fiery flavoring for a truly uplifting edible experience.
- Papa’s Herb: A California-founded brand focused on affordable and high-quality flower, concentrates and cartridges, sustainably sourced from generational family farms within the Emerald Triangle.
- PEACHES: The limited-edition pre-roll collaboration by Palms and Justin Bieber, featuring 3.5g packs of seven 0.5g pre-rolls in Sativa, Indica and Hybrid strains, all with a signature “peachy” flavor.
- Kush Co: Industry powerhouse Kush Co’s collaboration with iconic rapper YG on an exclusive strain combining elements of Jack Herer and OG for a euphoric high.
- Congo Club: Artisan-grown cannabis from the boutique cultivator behind Red Congolese, one of the most sought-after Bay Area strains.
- Nasha: Premium cold-water hash derived from small-batch, locally sourced craft cannabis.
- Insane by Dr. Greenthumb: Ultra-premium indoor cannabis from rapper B-Real.
This latest portfolio expansion is a testament to MedMen’s new era of post-turnaround accelerated growth and demonstrates the Company’s commitment to trusted, high-quality products and unparalleled service. MedMen’s full inventory of vaporizers, concentrates, pre-rolls and flower are available in stores or through the Company’s proprietary online ordering service for all patients and Buds rewards members.
To purchase MedMen products, please visit www.medmen.com , or find a dispensary near you at https://www.medmen.com/stores .
MedMen is a premier American cannabis retailer with an operational footprint in California, Nevada, Illinois, Arizona, Massachusetts, and Florida. MedMen offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red and LuxLyte through its premium retail stores, proprietary delivery service, as well as curbside and in-store pickup. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier, and happier. Learn more about MedMen at www.medmen.com .
MedMen Media Contact:
Lisa Weser, MedMen@Trailblaze.co
MedMen Investor Relations Contact:
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.